Oesophageal varices as an initial manifestation of JAK2-positive myeloproliferative neoplasms

被引：0
|
作者：
Link, C. [1 ]
Platzbecker, U. [1 ]
Brueckner, S. [1 ]
Thiede, C. [1 ]
Ehninger, G. [1 ]
Schuler, M. [1 ]
机构：
[1] Univ Klinikum Dresden, Med Klin 1, Dresden, Germany
来源：
ONKOLOGIE | 2012年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：50 / 50
页数：1
相关论文
共 50 条
  • [31] JAK2 inhibitors in the treatment of myeloproliferative neoplasms
    Tibes, Raoul
    Bogenberger, James M.
    Geyer, Holly L.
    Mesa, Ruben A.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (12) : 1755 - 1774
  • [32] MK-0457 is a novel aurora kinaseand janus kinase 2 inhibitor with activity in transformed JAK2-positive myeloproliferative disease
    Giles, J.
    Bergstrom, V. D. A.
    Garcia-Manero, G.
    Kornblau, S.
    Andreeff, M.
    Jones, D.
    Freedman, S. J.
    Verstovsek, S.
    Kantarjian, H.
    Rizzieri, D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 243 - 244
  • [33] Pacemaker lead-associated thrombus in JAK2-positive patient
    Peter, Laura Barbara
    ACTA CARDIOLOGICA, 2024, 79 (01) : 84 - 84
  • [34] Case series: patients with JAK2 positive myeloproliferative neoplasms associated with thrombotic events
    Combariza, J. F.
    Olaya, V
    Galvez, K.
    Ballesteros, L.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 88 - 88
  • [35] Overall Survival in Patients with JAK2 and ASXL1 Positive Myeloproliferative Neoplasms
    Al-Khabori, Murtadha
    Al-Zadjali, Shoaib
    Al Noumani, Iman
    Al Farsi, Khalil
    Al-Kindi, Salam
    Al Huneini, Mohamed
    Fawaz, Naglaa
    Sulayma, Al Lamki
    Al Bulushi, Mahdiya Pir
    Al Hashmi, Khalid
    Al Tarshi, Muna
    Almusalhi, Muhanna
    BLOOD, 2019, 134
  • [36] Acquired Angioedema as the Presenting Feature of a JAK2-Positive Essential Thrombocytosis
    Bajoghli, Amir
    Tran, Kayla
    Cunningham, Julia
    Bajoghli, Mehdi
    JCO ONCOLOGY PRACTICE, 2020, 16 (09) : 611 - +
  • [37] Association of JAK2 Mutation Status and Cytogenetic Abnormalities in Myeloproliferative Neoplasms and Myelodysplastic/Myeloproliferative Neoplasms
    Dunlap, Jennifer
    Kelemen, Katalin
    Leeborg, Nicky
    Braziel, Rita
    Olson, Susan
    Press, Richard
    Huang, James
    Gatter, Ken
    Loriaux, Marc
    Fan, Guang
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2011, 135 (05) : 709 - 719
  • [38] A germline JAK2 SNP is associated with predisposition to the development of JAK2V617F-positive myeloproliferative neoplasms
    Outi Kilpivaara
    Semanti Mukherjee
    Alison M Schram
    Martha Wadleigh
    Ann Mullally
    Benjamin L Ebert
    Adam Bass
    Sachie Marubayashi
    Adriana Heguy
    Guillermo Garcia-Manero
    Hagop Kantarjian
    Kenneth Offit
    Richard M Stone
    D Gary Gilliland
    Robert J Klein
    Ross L Levine
    Nature Genetics, 2009, 41 : 455 - 459
  • [39] A germline JAK2 SNP is associated with predisposition to the development of JAK2V617F-positive myeloproliferative neoplasms
    Kilpivaara, Outi
    Mukherjee, Semanti
    Schram, Alison M.
    Wadleigh, Martha
    Mullally, Ann
    Ebert, Benjamin L.
    Bass, Adam
    Marubayashi, Sachie
    Heguy, Adriana
    Garcia-Manero, Guillermo
    Kantarjian, Hagop
    Offit, Kenneth
    Stone, Richard M.
    Gilliland, D. Gary
    Klein, Robert J.
    Levine, Ross L.
    NATURE GENETICS, 2009, 41 (04) : 455 - 459
  • [40] Sensitivity and resistance of JAK2 inhibitors to myeloproliferative neoplasms
    Neha Bhagwat
    Ross L. Levine
    Priya Koppikar
    International Journal of Hematology, 2013, 97 : 695 - 702
12345